NEW YORK, April 06, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Citizens, Inc. (“Citizens” or the “Company”) (NYSE:CIA) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Citizens securities between March 11, 2015 through March 8, 2017, both dates inclusive (the “Class Period). Investors are encouraged to learn more about this case by visiting the firm’s site: http://www.bgandg.com/cia.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose that: (1) Citizens’ brokers and pitchbooks falsely claimed that most of the funds from its insurance policies were directly invested in U.S. Treasury Bond; (2) funds from Citizens’ insurance policies were funneled into continuous open market purchases that inflated Citizens’ stock price; and (3) consequently, defendants’ statements about Citizens’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On March 8, 2017, Seeking Alpha published a report alleging that although Citizen’s promises of “outsized ‘guaranteed’ returns backed by U..S. Treasury bonds,” the company’s funds are “not invested in U.S. Treasuries and [Citizen’s] policies appear designed to prop up Citizen’s stock price.” The article continued “[b]ecause most of the [Company’s] returns to existing policyholders are driven by funds contributed by new policyholders, Citizens displays some characteristics that appear analogous to a Ponzi scheme.” Following this news, Citizens stock dropped $0.45 per share or over 5% over the next two trading days to close at $8.00 per share on March 9, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/cia or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. You have until May 15, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 



